Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.
Porton Pharma Solutions: Value creation via innovation & discovery through technical platforms.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
ASMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.
About the Company : Transo-Pharm, a fully licensed and certified distributor, specializes in pharmaceutical components for the health and veterinary industries. It offers support to clients throughout...
Porton Pharma Solutions: Value creation via innovation & discovery through technical platforms.
About the Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities ar...
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - EQ 250MG BASE...DOSAGE - INJECTABLE;INJECTION - EQ 250MG BASE/VIAL
USFDA APPLICATION NUMBER - 20212
DOSAGE - INJECTABLE;INJECTION - EQ 500MG BASE...DOSAGE - INJECTABLE;INJECTION - EQ 500MG BASE/VIAL
USFDA APPLICATION NUMBER - 20212
DOSAGE - INJECTABLE;INJECTION - EQ 500MG BASE...DOSAGE - INJECTABLE;INJECTION - EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 22025
Related Excipient Companies
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
34
PharmaCompass offers a list of Dexrazoxane API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dexrazoxane manufacturer or Dexrazoxane supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dexrazoxane manufacturer or Dexrazoxane supplier.
PharmaCompass also assists you with knowing the Dexrazoxane API Price utilized in the formulation of products. Dexrazoxane API Price is not always fixed or binding as the Dexrazoxane Price is obtained through a variety of data sources. The Dexrazoxane Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dexrazoxane Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dexrazoxane Hydrochloride, including repackagers and relabelers. The FDA regulates Dexrazoxane Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dexrazoxane Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dexrazoxane Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dexrazoxane Hydrochloride supplier is an individual or a company that provides Dexrazoxane Hydrochloride active pharmaceutical ingredient (API) or Dexrazoxane Hydrochloride finished formulations upon request. The Dexrazoxane Hydrochloride suppliers may include Dexrazoxane Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Dexrazoxane Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dexrazoxane Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Dexrazoxane Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Dexrazoxane Hydrochloride DMFs exist exist since differing nations have different regulations, such as Dexrazoxane Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dexrazoxane Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Dexrazoxane Hydrochloride USDMF includes data on Dexrazoxane Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dexrazoxane Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dexrazoxane Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Dexrazoxane Hydrochloride Drug Master File in Japan (Dexrazoxane Hydrochloride JDMF) empowers Dexrazoxane Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Dexrazoxane Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Dexrazoxane Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Dexrazoxane Hydrochloride suppliers with JDMF on PharmaCompass.
A Dexrazoxane Hydrochloride written confirmation (Dexrazoxane Hydrochloride WC) is an official document issued by a regulatory agency to a Dexrazoxane Hydrochloride manufacturer, verifying that the manufacturing facility of a Dexrazoxane Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Dexrazoxane Hydrochloride APIs or Dexrazoxane Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Dexrazoxane Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Dexrazoxane Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dexrazoxane Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dexrazoxane Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dexrazoxane Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dexrazoxane Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dexrazoxane Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dexrazoxane Hydrochloride suppliers with NDC on PharmaCompass.
Dexrazoxane Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dexrazoxane Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dexrazoxane Hydrochloride GMP manufacturer or Dexrazoxane Hydrochloride GMP API supplier for your needs.
A Dexrazoxane Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Dexrazoxane Hydrochloride's compliance with Dexrazoxane Hydrochloride specifications and serves as a tool for batch-level quality control.
Dexrazoxane Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Dexrazoxane Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dexrazoxane Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Dexrazoxane Hydrochloride EP), Dexrazoxane Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dexrazoxane Hydrochloride USP).
